Association of TP53 codon 72 genotype polymorphism and environmental factors with esophageal squamous cell carcinoma in the Mongolian population of the Chinese region of Inner Mongolia

Li,Ming; Wang,Dapeng; Wang,Yumin; Sun,Guili; Song,Wanli; Zhang,Bin; Borjigin,Burenbatu

doi:10.3892/ol.2017.6374

Association of TP53 codon 72 genotype polymorphism and environmental factors with esophageal squamous cell carcinoma in the Mongolian population of the Chinese region of Inner Mongolia

Authors:
- Ming Li
- Dapeng Wang
- Yumin Wang
- Guili Sun
- Wanli Song
- Bin Zhang
- Burenbatu Borjigin
View Affiliations

Affiliations: Department of Oncology, Ezhou Central Hospital, Ezhou, Hubei 436000, P.R. China, Department of Oncology, Affiliated Hospital of Inner Mongolia University for The Nationalities, Tongliao, Inner Mongolia 028000, P.R. China, Department of Oncology, Affiliated Hospital of Chifeng University, Chifeng, Inner Mongolia 024005, P.R. China
Published online on: June 13, 2017 https://doi.org/10.3892/ol.2017.6374
Pages: 1484-1490
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study analyzed the association of tumor protein p53 (TP53) Pro72Arg polymorphism with esophageal squamous cell carcinoma (ESCC) in the Mongolian population of Tongliao (Inner Mongolia, China). Restriction fragment length polymorphism‑polymerase chain reaction was used to detect the genotype distribution of TP53 Pro72Arg polymorphism in 100 patients with ESCC and 50 healthy controls from the same population. Besides, the correlation between ESCC in Mongolian patients and various factors such as age, sex, cigarette smoking and alcohol consumption was analyzed. χ2 test revealed significant associations between alcohol consumption (P=0.00006) and cigarette smoking (P=0.00076) and ESCC in Mongolian patients. Notably, the Pro72 allele was significantly enriched in patients with ESCC compared with its abundance in the healthy control group, and the genotype of Pro/Arg on p53 codon 72 was confirmed to exhibit a significant correlation with ESCC in Mongolian patients. The present study demonstrated that alcohol drinking and cigarette smoking were risk factors for ESCC in the Mongolian population. Mongolian patients who carry the partocular genotype of Arg/Pro or Pro/Pro on p53 codon 72 may be more likely to develop ESCC. Compared with the p53 codon 72 genotype Arg/Arg, the TP53 Pro72 allele increased the risk of ESCC in Mongolian patients by 1.659‑fold.

View Figures

View References

1	Pennathur A, Gibson MK, Jobe BA and Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013. View Article : Google Scholar : PubMed/NCBI
2	Yang J, Liu B, Li W, Xiong H, Qiu H, Fu Q, Chen B, Hu G and Yuan X: Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC). Cancer Epidemiol. 37:629–633. 2013. View Article : Google Scholar : PubMed/NCBI
3	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
4	Enzinger PC and Mayer RJ: Esophageal cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
5	Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D and Kamangar F: High-temperature beverages and foods and esophageal cancer risk-a systematic review. Int J Cancer. 125:491–524. 2009. View Article : Google Scholar : PubMed/NCBI
6	Kamangar F, Chow WH, Abnet CC and Dawsey SM: Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 38:27–57, vii. 2009. View Article : Google Scholar : PubMed/NCBI
7	Zhang HZ, Jin GF and Shen HB: Epidemiologic differences in esophageal cancer between Asian and Western populations. Chin J Cancer. 31:281–286. 2012. View Article : Google Scholar : PubMed/NCBI
8	Gong Jinshan, Ao Shuyun and Ao Qimuge Deng: Related research of Mongolia national diet and esophageal cancer in Inner Mongolia area of Tongliao. Chinese Medical Guide. 1–451. 2013.
9	Davidoff AM, Iglehart JD and Marks JR: Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci USA. 89:pp. 3439–3442. 1992; View Article : Google Scholar : PubMed/NCBI
10	Vogiatzi P, Vindigni C, Roviello F, Renieri A and Giordano A: Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol. 211:287–295. 2007. View Article : Google Scholar : PubMed/NCBI
11	Li Y: Clinical study of reflux esophagitis in Mongolian. Inner Mongol J Med. 02:208–209. 2014.
12	Shimada H, Nabeya Y, Okazumi S, Matsubara H, Funami Y, Shiratori T, Hayashi H, Takeda A and Ochiai T: Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma. Surgery. 132:41–47. 2002. View Article : Google Scholar : PubMed/NCBI
13	Wang Z, Li X, Gao F, et al: Analysis of the incidence of malignant tumors in Hami area from 2010 to 2012. Xinjiang Med. 10:1501–1504. 2015.
14	Wu M, Zhao JK, Hu XS, Wang PH, Qin Y, Lu YC, Yang J, Liu AM, Wu DL, Zhang ZF, et al: Association of smoking, alcohol drinking and dietary factors with esophageal cancer in high- and low-risk areas of Jiangsu Province, China. World J Gastroenterol. 12:1686–1693. 2006. View Article : Google Scholar : PubMed/NCBI
15	Sakata K, Hoshiyama Y, Morioka S, Hashimoto T, Takeshita T and Tamakoshi A; JACC Study Group, : Smoking, alcohol drinking and esophageal cancer: Findings from the JACC Study. J Epidemiol. 15 Suppl 2:S212–S219. 2005. View Article : Google Scholar : PubMed/NCBI
16	Yang CX, Wang HY, Wang ZM, Du HZ, Tao DM, Mu XY, Chen HG, Lei Y, Matsuo K and Tajima K: Risk factors for esophageal cancer: A case-control study in South-western China. Asian Pac J Cancer Prev. 6:48–53. 2005.PubMed/NCBI
17	Castelli E, Hrelia P, Maffei F, Fimognari C, Foschi FG, Caputo F, Cantelli-Forti G, Stefanini GF and Gasbarrini G: Indicators of genetic damage in alcoholics: Reversibility after alcohol abstinence. Hepatogastroenterology. 46:1664–1668. 1999.PubMed/NCBI
18	Zhao Y, Wang F, Shan S, Zhao Y, Qiu X, Li X, Jiao F, Wang J and Du Y: Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk-a meta-analysis. Int J Med Sci. 7:300–308. 2010. View Article : Google Scholar : PubMed/NCBI
19	Altilia S, Santoro A, Malagoli D, Lanzarini C, Álvarez JA Ballesteros, Galazzo G, Porter DC, Crocco P, Rose G, Passarino G, et al: TP53 codon 72 polymorphism affects accumulation of mtDNA damage in human cells. Aging (Albany NY). 4:28–39. 2012. View Article : Google Scholar : PubMed/NCBI
20	Chen H, Yang X and Wang Z: Association between p53 Arg72Pro polymorphism and recurrent pregnancy loss: An updated systematic review and meta-analysis. Reprod Biomed Online. 31:149–153. 2015. View Article : Google Scholar : PubMed/NCBI
21	Papadakis EN, Dokianakis DN and Spandidos DA: p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Commun. 3:389–392. 2000. View Article : Google Scholar : PubMed/NCBI
22	Thomas M, Kalita A, Labrecque S, Pim D, Banks L and Matlashewski G: Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 19:1092–1100. 1999. View Article : Google Scholar : PubMed/NCBI
23	Pereira L, Carvalho MR, Fonseca CG, Lima SS, Cerqueira EM, Jorge W and Castro MC: Influence of Arg72Pro polymorphisms of TP53 on the response of buccal cells to radiotherapy. Genet Mol Res. 10:3552–3558. 2011. View Article : Google Scholar : PubMed/NCBI
24	Vogelstein B and Kinzler KW: p53 function and dysfunction. Cell. 70:523–526. 1992. View Article : Google Scholar : PubMed/NCBI
25	Piao JM, Kim HN, Song HR, Kweon SS, Choi JS, Yoon JY, Chung IJ, Kim SH and Shin MH: p53 codon 72 polymorphism and the risk of esophageal cancer: A Korean case-control study. Dis Esophagus. 24:596–600. 2011. View Article : Google Scholar : PubMed/NCBI
26	Hamajima N, Matsuo K, Suzuki T, Nakamura T, Matsuura A, Hatooka S, Shinoda M, Kodera Y, Yamamura Y, Hirai T, et al: No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett. 181:81–85. 2002. View Article : Google Scholar : PubMed/NCBI
27	Liu G, Cescon DW, Zhai R, Zhou W, Kulke MH, Ma C, Xu W, Su L, Asomaning K, Heist RS, et al: p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma. Dis Esophagus. 23:36–39. 2010. View Article : Google Scholar : PubMed/NCBI
28	Aida J, Yokoyama A, Shimomura N, Nakamura K, Ishikawa N, Terai M, Poon S, Matsuura M, Fujiwara M, Sawabe M, et al: Telomere shortening in the esophagus of Japanese alcoholics: Relationships with chromoendoscopic findings, ALDH2 and ADH1B genotypes and smoking history. PLoS One. 8:e638602013. View Article : Google Scholar : PubMed/NCBI
29	Buyru N, Altinisik J, Demokan S and Dalay N: p53 genotypes and haplotypes associated with risk of breast cancer. Cancer Detect Prev. 31:207–213. 2007. View Article : Google Scholar : PubMed/NCBI
30	Zehbe I, Voglino G, Wilander E, Genta F and Tommasino M: Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet. 354:218–219. 1999. View Article : Google Scholar : PubMed/NCBI
31	Jee SH, Lee JE and Park JS: Polymorphism of codon 72 of p53 and environmental factors in the development of cervical cancer. Int J Gynaecol Obstet. 80:69–70. 2003. View Article : Google Scholar : PubMed/NCBI
32	Buller RE, Sood A, Fullenkamp C, Sorosky J, Powills K and Anderson B: The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis. Cancer Gene Ther. 4:239–245. 1997.PubMed/NCBI
33	Buller RE, Shahin MS, Holmes RW, Hatterman M, Kirby PA and Sood AK: p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang. Am J Obstet Gynecol. 184:891–903. 2001. View Article : Google Scholar : PubMed/NCBI
34	Cai L, Mu LN, Lu H, Lu QY, You NC, Yu SZ, Le AD, Zhao J, Zhou XF, Marshall J, et al: Dietary selenium intake and genetic polymorphisms of the GSTP1 and p53 genes on the risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 15:294–300. 2006. View Article : Google Scholar : PubMed/NCBI
35	Zhang L, Xing D, He Z and Lin D: p53 gene codon 72 polymorphism and susceptibility to esophageal squamous cell carcinoma in a Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 19:10–13. 2002.(In Chinese). PubMed/NCBI
36	Hong Y, Miao X, Zhang X, Ding F, Luo A, Guo Y, Tan W, Liu Z and Lin D: The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma. Cancer Res. 65:9582–9587. 2005. View Article : Google Scholar : PubMed/NCBI
37	Ge H, Cao YY, Chen LQ, Wang YM, Chen ZF, Wen DG, Zhang XF, Guo W, Wang N, Li Y and Zhang JH: PTEN polymorphisms and the risk of esophageal carcinoma and gastric cardiac carcinoma in a high incidence region of China. Dis Esophagus. 21:409–415. 2008. View Article : Google Scholar : PubMed/NCBI